Product References — Innovative Grade US Origin Monkey Cynomolgus Serum

(November 22, 2016) Innovative Research's Innovative Grade US Origin Cyno Monkey Serum was recently used in the following study: Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies L Evgin, CS Ilkow, MC Bourgeois-Daigneault - Molecular Therapy , 2016... postadministration). As described with rat and mouse immune serum, neutralization was assessed following incubation of HI immune serum (1 hour; 37 C) GVB or with cynomolgus macaque serum (Innovative Research, Novi, MI)...

Innovative Research's Innovative Grade US Origin Cyno Monkey Serum was recently used in the following study: Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies L Evgin, CS Ilkow, MC Bourgeois-Daigneault - Molecular Therapy , 2016... postadministration). As described with rat and mouse immune serum, neutralization was assessed following incubation of HI immune serum (1 hour; 37 C) GVB or with cynomolgus macaque serum (Innovative Research, Novi, MI)...

Innovative Research's Innovative Grade US Origin Cyno Monkey Serum was recently used in the following study: Effect of animal sera on Bacillus anthracis Sterne spore germination and vegetative cell growthMD Bensman, RS Mackie, ZA Minter... - Journal of Applied ..., 2012 - Wiley Online Library...Sera used included foetal bovine, rabbit, rat, mouse, porcine, guinea pig, canine and feline sera (all purchased from Equitech-Bio, Kerrville, TX), as well as, cynomolgus monkey, rhesus monkey and pooled human AB sera (all purchased from Innovative Research, Novi, MI).

Innovative Research's Innovative Grade US Origin Cyno Monkey Serum was recently used in the following study: CD8 T Cells Define an Unexpected Role in Live-Attenuated Vaccine Protective Immunity against Chlamydia trachomatis Infection in MacaquesN Olivares-Zavaleta, WM Whitmire, L Kari - The Journal of Immunology, 2014with C. trachomatis A2497P using a multiplicity of infection of 1. Infected BGMK mono- layers were fed with Dulbecco's minimal essential medium (Cellgro, Manassas, VA) supplemented with 10% cynomolgus serum (Innovative Research, Novi, MI) and 10 mg/ml gentamicin.